JP2023544409A5 - - Google Patents

Info

Publication number
JP2023544409A5
JP2023544409A5 JP2023520448A JP2023520448A JP2023544409A5 JP 2023544409 A5 JP2023544409 A5 JP 2023544409A5 JP 2023520448 A JP2023520448 A JP 2023520448A JP 2023520448 A JP2023520448 A JP 2023520448A JP 2023544409 A5 JP2023544409 A5 JP 2023544409A5
Authority
JP
Japan
Prior art keywords
medical device
subject
dermatomyositis
suspected
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023520448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053540 external-priority patent/WO2022076388A1/en
Publication of JP2023544409A publication Critical patent/JP2023544409A/ja
Publication of JP2023544409A5 publication Critical patent/JP2023544409A5/ja
Pending legal-status Critical Current

Links

JP2023520448A 2020-10-05 2021-10-05 皮膚筋炎を治療する方法 Pending JP2023544409A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063087577P 2020-10-05 2020-10-05
US63/087,577 2020-10-05
PCT/US2021/053540 WO2022076388A1 (en) 2020-10-05 2021-10-05 Methods of treating dermatomyositis

Publications (2)

Publication Number Publication Date
JP2023544409A JP2023544409A (ja) 2023-10-23
JP2023544409A5 true JP2023544409A5 (enExample) 2024-10-15

Family

ID=81126239

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023520448A Pending JP2023544409A (ja) 2020-10-05 2021-10-05 皮膚筋炎を治療する方法

Country Status (10)

Country Link
US (1) US20230357442A1 (enExample)
EP (1) EP4225372A4 (enExample)
JP (1) JP2023544409A (enExample)
KR (1) KR20230084210A (enExample)
CN (1) CN116472065A (enExample)
AU (1) AU2021358027A1 (enExample)
CA (1) CA3172994A1 (enExample)
IL (1) IL301713A (enExample)
MX (1) MX2023004034A (enExample)
WO (1) WO2022076388A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250030978A (ko) * 2022-06-03 2025-03-05 알렉시온 파마슈티칼스, 인코포레이티드 중증 근무력증의 치료를 위한 융합 폴리펩티드의 투여량 및 투여
CN116313071B (zh) * 2023-01-16 2023-09-08 南方医科大学南方医院 一种预测初诊皮肌炎患者发生快速进展型间质性肺病的风险模型的构建方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794359A (en) * 1953-09-22 1957-06-04 Lyman Gun Sight Corp Automatic primer feed device
KR102071212B1 (ko) * 2010-04-21 2020-01-30 애브비 바이오테크놀로지 리미티드 치료제의 제어된 전달을 위한 착용형 자동 주사 디바이스
KR102149028B1 (ko) * 2012-02-20 2020-08-27 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 인간 보체 c5에 결합하는 폴리펩티드
US10531135B2 (en) * 2016-01-04 2020-01-07 Telefonaktiebolaget Lm Ericsson (Publ) Network recording apparatus
IL307197B2 (en) * 2017-07-11 2026-03-01 Alexion Pharma Inc Polypeptides that bind complement component c5 or serum albumin and fusion proteins thereof
MX2021011507A (es) * 2019-03-22 2021-12-15 Achillion Pharmaceuticals Inc Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento.
AU2022283254A1 (en) * 2021-05-25 2023-11-30 Alexion Pharmaceuticals, Inc. Kidney active fusion proteins and methods of treatment using the same
WO2023023220A1 (en) * 2021-08-20 2023-02-23 Alexion Pharmaceuticals, Inc. Methods for treating sickle cell disease or beta thalassemia using a complement alternative pathway inhibitor

Similar Documents

Publication Publication Date Title
JP2019194251A5 (enExample)
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
JPWO2019156137A5 (enExample)
JP2018138578A5 (enExample)
JP2015520188A5 (enExample)
MD3310809T2 (ro) Formularea anticorpului anti-CGRP
ATE535252T1 (de) Peptid-konjugat-zusammensetzungen und -verfahren zur prävention und behandlung von alzheimer- krankheit
JP2015518818A5 (enExample)
JP2007516966A5 (enExample)
JP2016514132A5 (enExample)
Tanno et al. Therapeutic approach of anaphylaxis
JP2018506550A5 (enExample)
JP2019533722A5 (enExample)
JP2018526460A5 (enExample)
JP2018509388A5 (enExample)
JP2018519366A5 (enExample)
JP2020535161A5 (enExample)
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
JP2017500316A5 (enExample)
JP2011500776A5 (enExample)
RU2019109154A (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ТЕРАПИИ ДЕФИЦИТА ГОРМОНА РОСТА, СОДЕРЖАЩАЯ СЛИТЫЙ БЕЛОК hGH
JP2009538916A5 (enExample)
JP2014509591A5 (enExample)
Suntsova et al. Use of romiplostim for newly diagnosed immune thrombocytopenia in children
JP2024500912A5 (enExample)